Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.

Audrey S L LowDeborah P M SymmonsMark LuntLouise K MercerChris P GaleKath D WatsonWilliam Gregory Dixon Kimmie L Hyrichnull null

Published in: Annals of the rheumatic diseases (2017)

Patients with RA receiving TNFi had a decreased risk of MI compared with patients with RA receiving sDMARD therapy over the medium term. This might be attributed to a direct action of TNFi on the atherosclerotic process or better overall disease control.

Keyphrases

rheumatoid arthritis
preterm infants
risk factors
left ventricular
ankylosing spondylitis
interstitial lung disease
systemic lupus erythematosus
replacement therapy